PepthenaDenmark

Home / Quality

How a lot
gets released

Seven stages from resin to released vial. A lot that fails any of them is destroyed — we do not have a second grade to sell it as.

Solid-phase synthesis

The sequence is built one residue at a time on a resin support, with coupling efficiency monitored at each step. A single failed coupling propagates as a deletion sequence through everything downstream.

Cleavage and precipitation

The chain is cleaved from the resin, side-chain protecting groups removed, and the crude peptide precipitated in cold ether. At this point purity is typically somewhere between 60 and 80 %.

Preparative HPLC

The crude material is separated on a reversed-phase column. Fractions are collected individually and assayed — only fractions that meet specification are pooled. This is the step that costs the yield and buys the purity.

Identity by mass spectrometry

Electrospray MS confirms the observed molecular weight against the theoretical weight of the intended sequence. A deviation here ends the lot; there is no interpretation to be done.

Purity by analytical HPLC

Reversed-phase, UV detection at 214 nm, area under curve. Release specification is ≥ 99 %. The chromatogram that appears on the certificate is the one from this run, unedited and unsmoothed.

Residuals and water content

Acetate counter-ion content, residual solvent and water by Karl Fischer titration. These are the numbers that determine how the powder behaves in the vial and how much peptide is actually in a nominal 10 mg fill.

Fill, quarantine, release

Lyophilisation, filling under laminar flow, crimping, then a −20 °C quarantine hold. Nothing ships until bioburden and endotoxin results are signed off and the certificate is issued against that specific lot number.

HPLC analysis in progress
Analytical HPLC · 214 nm · area-under-curve purity

A certificate of analysis and a vial on the bench
Certificate of analysis · lot PN-2607-114

The certificate

What a real COA
actually contains

A certificate of analysis is worth exactly as much as the traceability behind it. Plenty of certificates in this market are genuine documents describing a batch nobody in the supply chain still has.

Ours name the lot, the synthesis date, the analyst and the instrument. The chromatogram is a screenshot from the run, not a redrawn illustration. If the peak has a shoulder on it, you will see the shoulder.

Lot numberPN-2607-114
AppearanceWhite lyophilised powder
Identity (ESI-MS)Conforms
Purity (HPLC, 214 nm)99.4 %
Water content (KF)≤ 6.0 %
Acetate content≤ 15.0 %
Residual solventWithin ICH Q3C limits
Bacterial endotoxin< 1.0 EU/mg
Storage−20 °C, protect from light

Illustrative certificate values. The document supplied with your order carries the results for your lot.


What we do not claim

The honest
limits

A supplier that claims everything is claiming nothing. Here is the boundary of what a purity number can tell you.

Purity is not efficacy

A 99.4 % HPLC result tells you what is in the vial. It tells you nothing about whether the sequence does anything useful in your model. Those are separate questions and we only answer the first.

These are not medicines

Nothing in this catalogue holds a marketing authorisation as a medicinal product in Denmark or the EU. They are research chemicals, supplied for laboratory work, and we will not discuss human use.

Literature is not consensus

Most dose ranges on this site come from small preclinical studies. Where human data exists we say so; where it does not, the absence is the finding, and we do not fill the gap with confident language.

Ask for a certificate before you order

Send us a sequence and a lot number and we will email the certificate for it. No account required, no sales call attached.

Request a COA →